In furtherance of the August 20 Notice of the Ministry of Commerce on “Issuing the Overall Plan for Comprehensively Deepening the Innovation and Development of Service Trade” (商务部关于印发全面深化服务贸易创新发展试点总体方案的通知) (商服贸发)〔2020〕(165号), CNIPA issued two […]
IPO’s Comments on Recent Patent Legislation: Untangling a Complex Web
IPO’s Comments on recently proposed examination guidelines and on the SPC’s patent linkage reveal an increasingly complex web of IP legislation which is dependent on clarity in higher level laws.
Patent Data in a Pandemic
China’s first 10 month 2020 data shows a market increase in utility model patent applications. Is this a response to the pandemic? How does the data compare to USPTO filings for this period?
Berkeley Webinar Recap
China Daily just published an article on June 23 on our June 17, 2020 webinar on patent eligibility. The publication also coincided with a blog by Prof. Adam Mossoff on opposition to […]
China Patent and Licensing Discussions – Week of June 14th
On Wednesday, June 17th at 4:30 PM PST, former Chief Judge Paul Michel (ret.) will be moderating a star-studded panel hosted by Berkeley Law on one aspect of one of the great […]
100 Priority IP Projects for 2020
What does the recently released CNIPA document listing “100 Projects in 2020 to Deeply implement the National Intellectual Property Strategy to Accelerate the Construction of the Intellectual Property Powerful Country Promotion Plan” […]
Wang Binying and the Opportunity within the WIPO Crisis
The vote for WIPO Director General will be made in early March. The Chinese candidate, Madame Wang Binying, is known to many in the foreign IP community in China, IP diplomats, and […]
Second Annual Berkeley-Tsinghua Transnational IP Litigation Conference Is Fast Approaching
Berkeley Law and Tsinghua law will be co-hosting their Second Annual Conference on Transnational IP Litigation, at the campus of UC Berkeley on October 22, 2019. Details, including registration information, are available here. […]
China’s “Naked Bolar” and the Tapering Momentum to Protect Innovative Pharmaceuticals
There have been several important developments in recent weeks involving pharmaceutical IP protection in both mainland China and Taiwan. Based on these developments, mainland China appears to be slowing its momentum to […]
Collaboration or Confrontation: Beyond the False Dichotomy in US-China IP Relations
Recently several writers have criticized the Trump administration’s strategic choice of confrontation over collaboration with China. Among them was an open letter published in the July 2, 2019, Washington Post, “China is Not […]
China IPR - Intellectual Property Developments in China 